Mad upregulation and Id2 repression accompany transforming growth factor (TGF)-beta-mediated epithelial cell growth suppression.
about
Augmented cell survival in eutopic endometrium from women with endometriosis: expression of c-myc, TGF-beta1 and bax genes.HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cellsMechanisms of TGFβ-Induced Epithelial-Mesenchymal TransitionA role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiationTGF-beta repression of Id2 induces apoptosis in gut epithelial cellsId2 leaves the chromatin of the E2F4-p130-controlled c-myc promoter during hepatocyte priming for liver regenerationExpression of the type III TGF-beta receptor is negatively regulated by TGF-beta.Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility.Transforming growth factor-β and the hallmarks of cancer.Tak1, Smad4 and Trim33 redundantly mediate TGF-β3 signaling during palate development.JunB contributes to Id2 repression and the epithelial-mesenchymal transition in response to transforming growth factor-β.Genomic and proteomic profiling I: leiomyomas in African Americans and CaucasiansInterleukin-1 beta-induced Id2 gene expression is mediated by Egr-1 in vascular smooth muscle cells.The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer.Id2 is dispensable for Myc-induced epidermal neoplasia.Targeting the TGFβ signalling pathway in disease.Role of transforming growth factor-beta in cancer progression.Id2 Mediates Differentiation of Labyrinthine Placental Progenitor Cell Line, SM10.Alternative functions of core cell cycle regulators in neuronal migration, neuronal maturation, and synaptic plasticityTransformation of human ovarian surface epithelial cells by Krüppel-like factor 8.TGF-β in the Bone Microenvironment: Role in Breast Cancer Metastases.The role of TGF-β in bone metastasis: novel therapeutic perspectives.Biomarkers and signaling pathways of colorectal cancer stem cells.TGF-β Family Signaling in the Control of Cell Proliferation and Survival.Targeting TGF-β Signaling for Therapeutic Gain.Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.TGF-beta induces growth arrest in Burkitt lymphoma cells via transcriptional repression of E2F-1.Id proteins: novel targets of activin action, which regulate epidermal homeostasis.Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein.Mad3 negatively regulates B cell differentiation in the spleen by inducing Id2 expression.Different effection of p.1125Val>Ala and rs11954856 in APC on Wnt signaling pathway.Molecular mechanisms of Id2 down-regulation in rat liver after acetaminophen overdose. Protection by N-acetyl-L-cysteine.Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling.Molecular determinants of the interaction of Mad with the PAH2 domain of mSin3.Importance of inhibitor of DNA binding/differentiation 2 in hepatic stellate cell differentiation and proliferation.
P2860
Q24815636-0CFA0907-EE9B-41AC-AF5F-41E4023F4F3BQ25257668-31290452-2417-492F-8222-AAE810F9478FQ26745545-5526B17C-F15B-4268-B902-F2C5FD5FACF4Q28265320-8DA664A0-399F-4B31-8BDB-FA1CAFD0AE27Q28568288-C00FDE27-0FE6-4AA8-9673-0DF53743E974Q28579872-C917C405-1AF7-49AC-BACE-CD68620E90B7Q33986224-CA79A36D-1440-44F1-92AF-8DBE289547E7Q34650188-BD7BBCF2-37BD-4905-8B6C-5065958E972BQ34789300-172D292A-84F7-4FEF-AFBB-71B93F6CA64EQ35040180-C3ED93C4-89B0-45E7-AF20-CD78518E5FC4Q35839788-26CC379E-C0FB-417F-81C5-03C665825707Q36116691-7DF39952-6267-4550-B8CB-242629C3B334Q36168783-BBD6B324-A318-45E3-ADB9-9D6493C87A08Q36241260-1A9A8CAF-CB3E-4F83-8083-CEF0204B5290Q36421368-CDEE9B17-67A4-46E2-AC19-D6306FACB322Q36462348-ED3753CB-8E7B-4C54-8B0F-2C050E60B1B5Q36677493-B0CE6D46-4600-4350-B0BE-D6D6A87B716DQ37061300-9FC6B3CD-9965-44B6-B37A-CE324ADAF28FQ37375249-E8B6B75D-C2DE-443E-9E43-29ACB3C66641Q37685062-F06446EC-6458-4A7A-8CFD-E7AD2E51B0DFQ37900199-737A106E-63C6-4991-A25A-738302A2BC03Q38129383-FED209E2-A1B8-4C6A-855D-0351AC9F36D5Q38354849-3349408C-C901-450C-BB45-6A7EAF7950DFQ39029986-94C7CF13-A33A-4670-B41E-FD6BA66D6CB4Q39155151-43BBEA84-8824-4752-8144-4DD901B06F93Q39460209-45132007-D73C-41BA-B313-B4670C23A752Q39913896-800537C0-A1E5-4117-8066-DE4FA582BB2DQ40351364-23D8CE65-5C03-464D-A610-174AFEA73A2CQ40560477-52D10A97-3BB8-4032-AFD0-9DD1EBED13B1Q40786278-42E36D87-266E-4FF0-8B96-1A9A4EA15D54Q42378486-473355DF-80C3-41AC-A880-DD9C3DAA83D8Q42918174-657BB16C-2846-4653-AA5B-5191A4EB0971Q45881986-12D0030A-F59B-4195-A001-3681BF660612Q47871313-6BA77E3C-C843-45DB-B72F-BA7AF8EE5D16Q50678082-75F2B9CA-0AE4-49F1-AC5D-90053C57B017
P2860
Mad upregulation and Id2 repression accompany transforming growth factor (TGF)-beta-mediated epithelial cell growth suppression.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Mad upregulation and Id2 repre ...... elial cell growth suppression.
@ast
Mad upregulation and Id2 repre ...... elial cell growth suppression.
@en
Mad upregulation and Id2 repression accompany transforming growth factor
@nl
type
label
Mad upregulation and Id2 repre ...... elial cell growth suppression.
@ast
Mad upregulation and Id2 repre ...... elial cell growth suppression.
@en
Mad upregulation and Id2 repression accompany transforming growth factor
@nl
prefLabel
Mad upregulation and Id2 repre ...... elial cell growth suppression.
@ast
Mad upregulation and Id2 repre ...... elial cell growth suppression.
@en
Mad upregulation and Id2 repression accompany transforming growth factor
@nl
P2860
P356
P1476
Mad upregulation and Id2 repre ...... helial cell growth suppression
@en
P2093
Peter M Siegel
Weiping Shu
P2860
P304
35444-35450
P356
10.1074/JBC.M301413200
P407
P577
2003-06-24T00:00:00Z